Zura Bio Ltd (ZURA)

Currency in USD
1.495
+0.025(+1.70%)
Real-time Data·

ZURA Financial Summary

Key Ratios

P/E Ratio-1.69
Price/Book0.6
Debt / Equity0%
Return on Equity-55.05%
Dividend Yield0.00%
EBITDA-55.18M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2022
31/03
2022
31/12
2023
31/12
2024
31/12
* In Millions of USD (except for per share items)

Analyst Ratings

6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 13.667
(+814.16% Upside)

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-0.19 / -0.29
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What was Zura Bio Ltd's net income for the latest quarter?

Zura Bio Ltd's net income for the latest quarter was -17.44.

How does Zura Bio Ltd's debt to equity ratio compare to industry standards?

Zura Bio Ltd's total debt-to-equity ratio is 0.00%.

What is Zura Bio Ltd's return on investment on a TTM basis?

Zura Bio Ltd's trailing twelve months (TTM) return on investment (ROI) is -55.05%.

Did Zura Bio Ltd gain or lose cash last quarter?

In the latest quarter, Zura Bio Ltd's net change in cash was -5.93 million.

What were Zura Bio Ltd's total assets and liabilities in the latest quarter?

As of the latest quarter, Zura Bio Ltd reported total assets of 172.50 million and total liabilities of 21.09 million.

What was Zura Bio Ltd's revenue per share for the latest quarter?

Zura Bio Ltd's revenue per share for the latest quarter was 3.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.